psilocybin has been researched along with Dementia Praecox in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andel, D; Cahn, BR; Carter, OL; Kometer, M; Vollenweider, FX | 1 |
| PELICIER, Y | 1 |
| BONINO, D; GAMNA, G | 1 |
| Bäbler, A; Hell, D; Vogel, H; Vollenweider, FX; Vollenweider-Scherpenhuyzen, MF | 1 |
| Fukuda, K | 1 |
| Gillin, JC; Kleinman, JE; Wyatt, RJ | 1 |
| Keeler, MH | 1 |
| Rysánek, K | 1 |
| Bílý, D; Dubanský, B; Konias, V; Růzicková, R; Soucek, Z; Vyhnánková, M | 1 |
1 review(s) available for psilocybin and Dementia Praecox
| Article | Year |
|---|---|
[Relation of monoamines to mental disorders].
Topics: Amines; Animals; Bipolar Disorder; Catecholamines; Central Nervous System; Depression; Dihydroxyphenylalanine; Dopamine; Epinephrine; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Methylation; Monoamine Oxidase Inhibitors; Phenethylamines; Psilocybin; Reserpine; Schizophrenia; Serotonin; Tryptamines | 1970 |
1 trial(s) available for psilocybin and Dementia Praecox
| Article | Year |
|---|---|
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
Topics: Adult; Analysis of Variance; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Ketanserin; Male; Neuropsychological Tests; Psilocybin; Psychomotor Performance; Reaction Time; Reference Values; Schizophrenia; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |
7 other study(ies) available for psilocybin and Dementia Praecox
| Article | Year |
|---|---|
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
Topics: Adult; Cluster Analysis; Consciousness Disorders; Dose-Response Relationship, Drug; Electroencephalography; Female; Hallucinogens; Humans; Male; Neuropsychological Tests; Occipital Lobe; Parkinson Disease; Perceptual Closure; Photic Stimulation; Psilocybin; Psychometrics; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin Receptor Agonists; Visual Cortex | 2011 |
[SEROTONIN AND PSYCHIATRY].
Topics: Bipolar Disorder; Catecholamines; Drug Therapy; Hallucinations; Hallucinogens; Humans; Hydroxyindoleacetic Acid; Hypoglycemic Agents; Indoleacetic Acids; Lysergic Acid Diethylamide; Mescaline; Metabolism; Monoamine Oxidase Inhibitors; Phenothiazines; Psilocybin; Psychiatry; Psychotic Disorders; Research; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin | 1964 |
[STUDY OF MODIFICATIONS OF STEREOMORPHISMS OF A SCHIZOPHRENIC PATIENT BY MEANS OF PSYCHOPHARMACOLOGIC DRUGS].
Topics: Antidepressive Agents; Art; Hallucinogens; Humans; Lysergic Acid Diethylamide; Perphenazine; Psilocybin; Psychopharmacology; Research; Schizophrenia | 1964 |
Possible mechanisms of panic attack and schizophrenia via APUD system.
Topics: APUD Cells; Hallucinogens; Humans; Models, Biological; Panic Disorder; Psilocybin; Raphe Nuclei; Schizophrenia; Serotonin | 2002 |
A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
Topics: Adolescent; Adult; Amphetamines; Female; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Middle Aged; N,N-Dimethyltryptamine; Psilocybin; Psychoses, Substance-Induced; Schizophrenia | 1977 |
Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods.
Topics: Humans; Hypochondriasis; MMPI; Psilocybin; Schizophrenia; Visual Perception | 1965 |
[Effect of psilocybine in chronic schizophrenias. I. Clinical findings].
Topics: Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Psilocybin; Schizophrenia | 1967 |